News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Murali Janakiram: Rahul Banerjee nearly convinced me to wait for CAR T
Photos of Murali Janakiram and Rahul Banerjee
Jul 29, 2024, 23:24

Murali Janakiram: Rahul Banerjee nearly convinced me to wait for CAR T

Murali Janakiram, Associate Professor of Division of Hematological Malignancies at City of Hope, shared a post on X:

“CART should wait – Rahul Banerjee

  • He nearly convinced me
  • Wait for the new CART”

Murali Janakiram

Source: Murali Janakiram/X

cancer City of Hope Murali Janakiram OncoDaily Oncology Rahul Banerjee
Special Coverage
Career
Dec 12, 2024, 21:03
Riya Patel: I am Medical Oncology certified
Blog
Dec 12, 2024, 20:59
Francisco Esteva: De-escalating neoadjuvant chemotherapy in HER2+ breast cancer
Opinion
Dec 12, 2024, 20:55
Elisa Agostinetto: Very much awaited results of EMBER-3 at SABCS24
Blog
Dec 12, 2024, 20:52
Hope Rugo: MBC HER2+ PHILA study presented at SABCS 2024
Blog
Dec 12, 2024, 20:49
Stephanie Graff: Important global data from PHILA study
Blog
Dec 12, 2024, 20:45
Sara Tolaney: Beautiful discussion of EMBER-3 by Harold Burstein
Blog
Dec 12, 2024, 20:42
Arya Roy: Kicking off SABCS24 on a high note with the Coltman Scholar Award Notification
Blog
Dec 12, 2024, 20:39
The Journal of Experimental Medicine - Important roles of STAG2 in suppressing lung tumorigenesis
Blog
Dec 12, 2024, 20:39
Mechanisms of Obesity Related Risk for Breast Cancer and Approaches to Risk Reduction
Blog
Dec 12, 2024, 20:39
Ada Waks on the management of small HER2+ breast cancers
Blog
Dec 12, 2024, 20:39
Imlunestrant + abemaciclib likely to become a new 2L treatment option for HR+/HER2- Metastatic breast cancer
Blog
Dec 12, 2024, 20:39
Paolo Tarantino: SHR-A1811 x8 +/- pyrotinib vs TCHP for stage III HER2+ early breast cancer